Antimicrobial polymer-siRNA polyplexes as a dual-mode platform for the treatment of wound biofilm infections

Treatment of wound biofilm infections faces challenges from both pathogens and uncontrolled host immune response. Treating both issues through a single vector would provide enhanced wound healing. Here, we report the use of a potent cationic antimicrobial polymer to generate siRNA polyplexes for dual-mode treatment of wound biofilms in vivo. These polyplexes act both as an antibiofilm agent and a delivery vehicle for siRNA for the knockdown of biofilm-associated pro-inflammatory MMP9 in host macrophages. The resulting polyplexes were effective in vitro, eradicating MRSA biofilms and efficiently delivering siRNA to macrophages in vitro with concomitant knockdown of MMP9. These polyplexes were likewise effective in an in vivo murine wound biofilm model, significantly reducing bacterial load in the wound (similar to 99% bacterial clearance) and reducing MMP9 expression by 80% (qRT-PCR). This combination therapeutic strategy dramatically reduced wound purulence and significantly expedited wound healing. Taken together, these polyplexes provide an effective and translatable strategy for managing biofilm-infected wounds. Dual therapeutics use cationic polymers to kill bacteria and deliver siRNA to macrophages to decrease inflammation and enhance wound healing.

Automated summary

This study presents the use of a cationic antimicrobial polymer to generate siRNA polyplexes for dual-mode treatment of wound biofilms. These polyplexes act as both antibiofilm agents and siRNA delivery vehicles to reduce inflammation and enhance wound healing. In vitro and in vivo experiments showed promising results, significantly reducing bacterial load and MMP9 expression, and speeding up wound healing.